| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a3febfbd930318f2b7418da1deddb9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 |
| filingDate |
2008-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43a18ee8dbd15ea227214f97ff024aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c06b023b2f001be6fa36c04a7ae800
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139e17179c58b14088fee41e53f76c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_338b22d5e5ab2528d0beee9f8435f667 |
| publicationDate |
2014-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2783692-A1 |
| titleOfInvention |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| abstract |
The invention provides a composition comprising a population of isolated cells that comprise CD56 + , CD16 - placental intermediate natural killer cells obtainable by perfusion of a human placenta that has been drained of cord blood and flushed to remove residual blood to produce placental perfusate comprising nucleated placental cells and isolation of the nucleated placental cells from said placental perfusate, wherein said population comprises at least about 50% CD56 + , CD16 - placental intermediate natural killer cells. The composition may further comprise isolated CD56 + , CD16 + natural killer cells and/or isolated placental perfusate. The composition may further comprise natural killer cells isolated from umbilical cord blood, wherein said umbilical cord blood is isolated from the placenta from which the placental perfusate was obtained |
| priorityDate |
2007-09-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |